Literature DB >> 25197781

Management of gastric cancer.

Geoffrey Y Ku1, David H Ilson.   

Abstract

PURPOSE OF REVIEW: Gastric cancer is an uncommon cancer in the United States but is a very common cancer globally and is endemic in East Asia. It is a virulent cancer that presents with metastatic disease in about one half of United States patients. RECENT
FINDINGS: In this review article, we discuss palliative chemotherapy options as well as validated preoperative, perioperative and postoperative strategies for locally advanced disease, which include chemotherapy and/or chemoradiation.
SUMMARY: In the metastatic setting, there has been incremental improvement in cytotoxic chemotherapy combinations in the past 2 decades. Two targeted agents - trastuzumab and ramucirumab - are now approved. In the locally advanced setting, perioperative chemotherapy or postoperative chemotherapy or chemoradiation improves outcomes relative to surgery alone.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25197781     DOI: 10.1097/MOG.0000000000000115

Source DB:  PubMed          Journal:  Curr Opin Gastroenterol        ISSN: 0267-1379            Impact factor:   3.287


  7 in total

1.  Palliative radiotherapy for gastric cancer: Is there a dose relationship between bleeding response and radiotherapy?

Authors:  Gustavo Arruda Viani; Caio Viani Arruda; Ana Carolina Hamamura; Alexandre Ciufi Faustino; Anielle Freitas Bendo Danelichen; Fernando Kojo Matsuura; Leonardo Vicente Fay Neves
Journal:  Clinics (Sao Paulo)       Date:  2020-09-02       Impact factor: 2.365

2.  Patient preferences for palliative treatment of locally advanced or metastatic gastric cancer and adenocarcinoma of the gastroesophageal junction: a choice-based conjoint analysis study from Germany.

Authors:  R Hofheinz; J Clouth; J Borchardt-Wagner; U Wagner; E Weidling; M H Jen; P Brück
Journal:  BMC Cancer       Date:  2016-12-06       Impact factor: 4.430

Review 3.  Positioning of second-line treatment for advanced gastric and gastroesophageal junction adenocarcinoma.

Authors:  Carles Pericay; Fernando Rivera; Carlos Gomez-Martin; Inmaculada Nuñez; Alejo Cassinello; Esteban Rodrigo Imedio
Journal:  Cancer Med       Date:  2016-10-24       Impact factor: 4.452

4.  Palliative external beam radiotherapy for the treatment of tumor bleeding in inoperable advanced gastric cancer.

Authors:  Yun Hee Lee; Jeong Won Lee; Hong Seok Jang
Journal:  BMC Cancer       Date:  2017-08-12       Impact factor: 4.430

5.  The Antioxidant Alpha-Lipoic Acid Inhibits Proliferation and Invasion of Human Gastric Cancer Cells via Suppression of STAT3-Mediated MUC4 Gene Expression.

Authors:  Yu Yang; Erhu Fang; Jiajun Luo; Hongxue Wu; Yue Jiang; Ying Liu; Shilun Tong; Zhihua Wang; Rui Zhou; Qiang Tong
Journal:  Oxid Med Cell Longev       Date:  2019-12-13       Impact factor: 6.543

6.  SP1-Induced Upregulation of lncRNA LINC00659 Promotes Tumour Progression in Gastric Cancer by Regulating miR-370/AQP3 Axis.

Authors:  Yao Wang; Yuanyuan Guo; Tianchi Zhuang; Ting Xu; Minghui Ji
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-26       Impact factor: 6.055

7.  Prevalence of Germline Alterations on Targeted Tumor-Normal Sequencing of Esophagogastric Cancer.

Authors:  Geoffrey Y Ku; Yelena Kemel; Steve B Maron; Joanne F Chou; Vignesh Ravichandran; Zarina Shameer; Anna Maio; Elizabeth S Won; David P Kelsen; David H Ilson; Marinela Capanu; Vivian E Strong; Daniela Molena; Smita Sihag; David R Jones; Daniel G Coit; Yaelle Tuvy; Kendall Cowie; David B Solit; Nikolaus Schultz; Jaclyn F Hechtman; Kenneth Offit; Vijai Joseph; Diana Mandelker; Yelena Y Janjigian; Zsofia K Stadler
Journal:  JAMA Netw Open       Date:  2021-07-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.